Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer?

被引：0
作者：
Pecorelli, Sergio
Odicino, Franco
机构：
[1] Univ Brescia, Dept Obstet & Gynecol, Div Gynecol Oncol, I-25123 Brescia, Italy
[2] Univ Brescia, Dept Obstet & Gynecol, Brescia, Italy
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2007年 / 4卷 / 06期
关键词：
carboplatin; gemcitabine; ovarian cancer; progression-free survival; response rate;
D O I：
10.1038/ncponc0795
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：340 / 341
页数：2
相关论文
共 5 条
  • [1] Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer -: a dose-finding study by the Arbeitsgemeinschaft Gynakologische Onkologie (AGO) Ovarian Cancer Study Group
    du Bois, A
    Lück, HJ
    Pfisterer, J
    Schroeder, W
    Blohmer, JU
    Kimmig, R
    Moebus, V
    Quaas, J
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (08) : 1115 - 1120
  • [2] A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma
    Kose, MF
    Sufliarsky, J
    Beslija, S
    Saip, P
    Tulunay, G
    Krejcy, K
    Minarik, T
    Fitzthum, E
    Hayden, A
    Melemed, A
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 96 (02) : 374 - 380
  • [3] Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients - A Hellenic Cooperative Oncology Group Study
    Papadimitriou, CA
    Fountzilas, G
    Aravantinos, G
    Kalofonos, C
    Moulopoulos, LA
    Briassoulis, E
    Gika, D
    Dimopoulos, MA
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 152 - 159
  • [4] Parmar MKB, 2003, LANCET, V361, P2099
  • [5] Management of platinum-sensitive recurrent ovarian cancer
    Pfisterer, Jacobus
    Ledermann, Jonathan A.
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (02) : S12 - S16
1